Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 4/6 |
STERIS plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$228.50 |
52 Week High | US$254.00 |
52 Week Low | US$195.47 |
Beta | 0.81 |
1 Month Change | 9.95% |
3 Month Change | -0.25% |
1 Year Change | 10.23% |
3 Year Change | 16.75% |
5 Year Change | 62.69% |
Change since IPO | 10,978.79% |
Recent News & Updates
Recent updates
Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Is STERIS (NYSE:STE) A Risky Investment?
Jul 19Steris: Deleveraging Key Undercurrent, Valuation A Concern
Jun 12STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Apr 08Steris: Another Essential Healthcare Supply Resource
Feb 01Shareholder Returns
STE | US Medical Equipment | US Market | |
---|---|---|---|
7D | 2.3% | -0.6% | -0.6% |
1Y | 10.2% | 2.1% | 22.4% |
Return vs Industry: STE exceeded the US Medical Equipment industry which returned 2.1% over the past year.
Return vs Market: STE underperformed the US Market which returned 22.4% over the past year.
Price Volatility
STE volatility | |
---|---|
STE Average Weekly Movement | 3.6% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: STE has not had significant price volatility in the past 3 months.
Volatility Over Time: STE's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 18,000 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
STE fundamental statistics | |
---|---|
Market cap | US$22.59b |
Earnings (TTM) | US$551.44m |
Revenue (TTM) | US$5.14b |
41.0x
P/E Ratio4.4x
P/S RatioIs STE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
STE income statement (TTM) | |
---|---|
Revenue | US$5.14b |
Cost of Revenue | US$2.90b |
Gross Profit | US$2.24b |
Other Expenses | US$1.69b |
Earnings | US$551.44m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.58 |
Gross Margin | 43.52% |
Net Profit Margin | 10.73% |
Debt/Equity Ratio | 50.8% |
How did STE perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield36%
Payout RatioDoes STE pay a reliable dividends?
See STE dividend history and benchmarksSTERIS dividend dates | |
---|---|
Ex Dividend Date | Jun 12 2024 |
Dividend Pay Date | Jun 26 2024 |
Days until Ex dividend | 7 days |
Days until Dividend pay date | 21 days |
Does STE pay a reliable dividends?
See STE dividend history and benchmarks